{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:35:38Z","timestamp":1791293738053,"version":"4.1.0"},"reference-count":193,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T00:00:00Z","timestamp":1494806400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1038\/nrneph.2017.60","type":"journal-article","created":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T04:11:35Z","timestamp":1494821495000},"page":"429-442","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":298,"title":["Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD"],"prefix":"10.1038","volume":"13","author":[{"given":"Mathias","family":"Haarhaus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Brandenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamyar","family":"Kalantar-Zadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Stenvinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Magnusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,15]]},"reference":[{"key":"BFnrneph201760_CR1","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/sj.ki.5002343","volume":"72","author":"AS Levey","year":"2007","unstructured":"Levey, A. S. et al. Chronic kidney disease as a global public health problem: approaches and initiatives \u2014 a position statement from kidney disease improving global outcomes. Kidney Int. 72, 247\u2013259 (2007).","journal-title":"Kidney Int."},{"key":"BFnrneph201760_CR2","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/j.1365-2796.2010.02269.x","volume":"268","author":"P Stenvinkel","year":"2010","unstructured":"Stenvinkel, P. Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease. J. Intern. Med. 268, 456\u2013467 (2010).","journal-title":"J. Intern. Med."},{"key":"BFnrneph201760_CR3","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"A Go","year":"2004","unstructured":"Go, A., Chertow, G., Fan, D., McCulloch, C. & Hsu, C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351, 1296\u20131305 (2004).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201760_CR4","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1053\/j.ajkd.2015.10.011","volume":"67","author":"X Xie","year":"2016","unstructured":"Xie, X. et al. Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: a Bayesian network meta-analysis of randomized clinical trials. Am. J. Kidney Dis. 67, 728\u2013741 (2016).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201760_CR5","first-page":"CD007784","volume":"5","author":"SC Palmer","year":"2014","unstructured":"Palmer, S. C. et al. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst. Rev. 5, CD007784 (2014).","journal-title":"Cochrane Database Syst. Rev."},{"key":"BFnrneph201760_CR6","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1053\/j.ajkd.2012.11.051","volume":"62","author":"P Stenvinkel","year":"2013","unstructured":"Stenvinkel, P. & Larsson, T. E. Chronic kidney disease: a clinical model of premature aging. Am. J. Kidney Dis. 62, 339\u2013351 (2013).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201760_CR7","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nrneph.2014.185","volume":"10","author":"JP Kooman","year":"2014","unstructured":"Kooman, J. P., Kotanko, P., Schols, A. M., Shiels, P. G. & Stenvinkel, P. Chronic kidney disease and premature ageing. Nat. Rev. Nephrol. 10, 732\u2013742 (2014).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrneph201760_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10741-014-9460-9","volume":"20","author":"L Di Lullo","year":"2015","unstructured":"Di Lullo, L. et al. Chronic kidney disease and cardiovascular complications. Heart Fail. Rev. 20, 259\u2013272 (2015).","journal-title":"Heart Fail. Rev."},{"key":"BFnrneph201760_CR9","doi-asserted-by":"publisher","first-page":"e102276","DOI":"10.1371\/journal.pone.0102276","volume":"9","author":"JW Li","year":"2014","unstructured":"Li, J. W., Xu, C., Fan, Y., Wang, Y. & Xiao, Y. B. Can serum levels of alkaline phosphatase and phosphate predict cardiovascular diseases and total mortality in individuals with preserved renal function? A systemic review and meta-analysis. PLoS ONE 9, e102276 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrneph201760_CR10","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/joim.12464","volume":"279","author":"IR Reid","year":"2016","unstructured":"Reid, I. R., Gamble, G. D. & Bolland, M. J. Circulating calcium concentrations, vascular disease and mortality: a systematic review. J. Intern. Med. 279, 524\u2013540 (2016).","journal-title":"J. Intern. Med."},{"key":"BFnrneph201760_CR11","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.2215\/CJN.10091110","volume":"6","author":"C Drechsler","year":"2011","unstructured":"Drechsler, C. et al. Bone alkaline phosphatase and mortality in dialysis patients. Clin. J. Am. Soc. Nephrol. 6, 1752\u20131759 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201760_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/3527608060","volume-title":"Mammalian Alkaline Phosphatase: From Biology to Applications in Medicine and Biotechnology","author":"JL Millan","year":"2006","unstructured":"Millan, J. L. Mammalian Alkaline Phosphatase: From Biology to Applications in Medicine and Biotechnology (Wiley, 2006)."},{"key":"BFnrneph201760_CR13","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1359\/jbmr.1997.12.2.210","volume":"12","author":"P Magnusson","year":"1997","unstructured":"Magnusson, P., Degerblad, M., S\u00e4\u00e4f, M., Larsson, L. & Thor\u00e9n, M. Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-i (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency. J. Bone Miner. Res. 12, 210\u2013220 (1997).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrneph201760_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0378-4347(92)80177-R","volume":"576","author":"P Magnusson","year":"1992","unstructured":"Magnusson, P., L\u00f6fman, O. & Larsson, L. Determination of alkaline phosphatase isoenzymes in serum by high-performance liquid chromatography with post-column reaction detection. J. Chromatogr. 576, 79\u201386 (1992).","journal-title":"J. Chromatogr."},{"key":"BFnrneph201760_CR15","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s00223-001-1137-4","volume":"71","author":"P Magnusson","year":"2002","unstructured":"Magnusson, P. & Farley, J. Differences in sialic acid residues among bone alkaline phosphatase isoforms: a physical, biochemical, and immunological characterization. Calcif. Tissue Int. 71, 508\u2013518 (2002).","journal-title":"Calcif. Tissue Int."},{"key":"BFnrneph201760_CR16","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.bone.2009.07.009","volume":"45","author":"C Halling Linder","year":"2009","unstructured":"Halling Linder, C., Narisawa, S., Mill\u00e1n, J. & Magnusson, P. Glycosylation differences contribute to distinct catalytic properties among bone alkaline phosphatase isoforms. Bone 45, 987\u2013993 (2009).","journal-title":"Bone"},{"key":"BFnrneph201760_CR17","doi-asserted-by":"crossref","first-page":"12002","DOI":"10.1016\/S0021-9258(18)37885-2","volume":"263","author":"MJ Weiss","year":"1988","unstructured":"Weiss, M. J. et al. Structure of the human liver\/bone\/kidney alkaline phosphatase gene. J. Biol. Chem. 263, 12002\u201312010 (1988).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201760_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10408369509084680","volume":"32","author":"JL Mill\u00e1n","year":"1995","unstructured":"Mill\u00e1n, J. L. & Fishman, W. H. Biology of human alkaline phosphatases with special reference to cancer. Crit. Rev. Clin. Lab. Sci. 32, 1\u201339 (1995).","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"BFnrneph201760_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1159\/000067254","volume":"23","author":"P Magnusson","year":"2002","unstructured":"Magnusson, P. et al. Monoclonal antibodies against tissue-nonspecific alkaline phosphatase. Report of the ISOBM TD9 workshop. Tumour Biol. 23, 228\u2013248 (2002).","journal-title":"Tumour Biol."},{"key":"BFnrneph201760_CR20","doi-asserted-by":"publisher","first-page":"31171","DOI":"10.1074\/jbc.M102788200","volume":"276","author":"E Mornet","year":"2001","unstructured":"Mornet, E. et al. Structural evidence for a functional role of human tissue nonspecific alkaline phosphatase in bone mineralization. J. Biol. Chem. 276, 31171\u201331178 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201760_CR21","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1002\/mnfr.201000659","volume":"55","author":"EH Alcantara","year":"2011","unstructured":"Alcantara, E. H. et al. Zinc deprivation inhibits extracellular matrix calcification through decreased synthesis of matrix proteins in osteoblasts. Mol. Nutr. Food Res. 55, 1552\u20131560 (2011).","journal-title":"Mol. Nutr. Food Res."},{"key":"BFnrneph201760_CR22","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1038\/2071292b0","volume":"207","author":"FW Heaton","year":"1965","unstructured":"Heaton, F. W. Effect of magnesium deficiency on plasma alkaline phosphatase activity. Nature 207, 1292\u20131293 (1965).","journal-title":"Nature"},{"key":"BFnrneph201760_CR23","doi-asserted-by":"publisher","first-page":"e0119874","DOI":"10.1371\/journal.pone.0119874","volume":"10","author":"MF Hoylaerts","year":"2015","unstructured":"Hoylaerts, M. F. et al. Functional significance of calcium binding to tissue-nonspecific alkaline phosphatase. PLoS ONE 10, e0119874 (2015).","journal-title":"PLoS ONE"},{"key":"BFnrneph201760_CR24","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/0003-9861(88)90305-0","volume":"264","author":"KN Fedde","year":"1988","unstructured":"Fedde, K. N., Lane, C. C. & Whyte, M. P. Alkaline phosphatase is an ectoenzyme that acts on micromolar concentrations of natural substrates at physiologic pH in human osteosarcoma (SAOS-2) cells. Arch. Biochem. Biophys. 264, 400\u2013409 (1988).","journal-title":"Arch. Biochem. Biophys."},{"key":"BFnrneph201760_CR25","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1146\/annurev.bi.64.070195.003023","volume":"64","author":"S Udenfriend","year":"1995","unstructured":"Udenfriend, S. & Kodukula, K. How glycosylphosphatidylinositol-anchored membrane proteins are made. Annu. Rev. Biochem. 64, 563\u2013591 (1995).","journal-title":"Annu. Rev. Biochem."},{"key":"BFnrneph201760_CR26","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/0304-4157(89)90014-2","volume":"988","author":"MG Low","year":"1989","unstructured":"Low, M. G. The glycosyl-phosphatidylinositol anchor of membrane proteins. Biochim. Biophys. Acta 988, 427\u2013454 (1989).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrneph201760_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0009-8981(97)00161-7","volume":"266","author":"NM Hooper","year":"1997","unstructured":"Hooper, N. M. Glycosyl-phosphatidylinositol anchored membrane enzymes. Clin. Chim. Acta 266, 3\u201312 (1997).","journal-title":"Clin. Chim. Acta"},{"key":"BFnrneph201760_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0009-8981(02)00248-6","volume":"325","author":"P Magnusson","year":"2002","unstructured":"Magnusson, P., Sharp, C. A. & Farley, J. R. Different distributions of human bone alkaline phosphatase isoforms in serum and bone tissue extracts. Clin. Chim. Acta 325, 59\u201370 (2002).","journal-title":"Clin. Chim. Acta"},{"key":"BFnrneph201760_CR29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0009-8981(01)00584-8","volume":"311","author":"DJ Anh","year":"2001","unstructured":"Anh, D. J., Eden, A. & Farley, J. R. Quantitation of soluble and skeletal alkaline phosphatase, and insoluble alkaline phosphatase anchor-hydrolase activities in human serum. Clin. Chim. Acta 311, 137\u2013148 (2001).","journal-title":"Clin. Chim. Acta"},{"key":"BFnrneph201760_CR30","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1006\/abio.1993.1247","volume":"211","author":"P Magnusson","year":"1993","unstructured":"Magnusson, P., L\u00f6fman, O. & Larsson, L. Methodological aspects on separation and reaction conditions of bone and liver alkaline phosphatase isoform analysis by high-performance liquid chromatography. Anal. Biochem. 211, 156\u2013163 (1993).","journal-title":"Anal. Biochem."},{"key":"BFnrneph201760_CR31","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1046\/j.1523-1755.2001.00794.x","volume":"60","author":"P Magnusson","year":"2001","unstructured":"Magnusson, P. et al. Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms. Kidney Int. 60, 257\u2013265 (2001).","journal-title":"Kidney Int."},{"key":"BFnrneph201760_CR32","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1203\/00006450-199512000-00021","volume":"38","author":"P Magnusson","year":"1995","unstructured":"Magnusson, P., H\u00e4ger, A. & Larsson, L. Serum osteocalcin and bone and liver alkaline phosphatase isoforms in healthy children and adolescents. Pediatr. Res. 38, 955\u2013961 (1995).","journal-title":"Pediatr. Res."},{"key":"BFnrneph201760_CR33","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1093\/clinchem\/44.8.1621","volume":"44","author":"P Magnusson","year":"1998","unstructured":"Magnusson, P. et al. Differences of bone alkaline phosphatase isoforms in metastatic bone disease and discrepant effects of clodronate on different skeletal sites indicated by the location of pain. Clin. Chem. 44, 1621\u20131628 (1998).","journal-title":"Clin. Chem."},{"key":"BFnrneph201760_CR34","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3109\/00365511003642527","volume":"70","author":"P Magnusson","year":"2010","unstructured":"Magnusson, P., Davie, M. & Sharp, C. Circulating and tissue-derived isoforms of bone alkaline phosphatase in Paget's disease of bone. Scand. J. Clin. Lab. Invest. 70, 128\u2013135 (2010).","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"BFnrneph201760_CR35","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1359\/jbmr.1999.14.11.1926","volume":"14","author":"P Magnusson","year":"1999","unstructured":"Magnusson, P., Larsson, L., Magnusson, M., Davie, M. & Sharp, C. Isoforms of bone alkaline phosphatase: characterization and origin in human trabecular and cortical bone. J. Bone Miner. Res. 14, 1926\u20131933 (1999).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrneph201760_CR36","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s00467-006-0231-2","volume":"21","author":"D Swolin-Eide","year":"2006","unstructured":"Swolin-Eide, D., Hansson, S., Larsson, L. & Magnusson, P. The novel bone alkaline phosphatase b1x isoform in children with kidney disease. Pediatr. Nephrol. 21, 1723\u20131729 (2006).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201760_CR37","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1093\/ndt\/gfp300","volume":"24","author":"M Haarhaus","year":"2009","unstructured":"Haarhaus, M., Fernstr\u00f6m, A., Magnusson, M. & Magnusson, P. Clinical significance of bone alkaline phosphatase isoforms, including the novel b1x isoform, in mild to moderate chronic kidney disease. Nephrol. Dial. Transplant. 24, 3382\u20133389 (2009).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201760_CR38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1053\/j.ajkd.2015.02.323","volume":"66","author":"M Haarhaus","year":"2015","unstructured":"Haarhaus, M., Monier-Faugere, M. C., Magnusson, P. & Malluche, H. H. Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study. Am. J. Kidney Dis. 66, 99\u2013105 (2015).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201760_CR39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1161\/01.RES.0000026421.61398.F2","volume":"91","author":"A Shioi","year":"2002","unstructured":"Shioi, A. et al. Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages. Circ. Res. 91, 9\u201316 (2002).","journal-title":"Circ. Res."},{"key":"BFnrneph201760_CR40","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000346161","volume":"50","author":"M Haarhaus","year":"2013","unstructured":"Haarhaus, M., Arnqvist, H. J. & Magnusson, P. Calcifying human aortic smooth muscle cells express different bone alkaline phosphatase isoforms, including the novel b1x isoform. J. Vasc. Res. 50, 167\u2013174 (2013).","journal-title":"J. Vasc. Res."},{"key":"BFnrneph201760_CR41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000380991","volume":"28","author":"P Grabowski","year":"2015","unstructured":"Grabowski, P. Physiology of bone. Endocr. Dev. 28, 33\u201355 (2015).","journal-title":"Endocr. Dev."},{"key":"BFnrneph201760_CR42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.yexcr.2013.12.012","volume":"325","author":"F Bleicher","year":"2014","unstructured":"Bleicher, F. Odontoblast physiology. Exp. Cell Res. 325, 65\u201371 (2014).","journal-title":"Exp. Cell Res."},{"key":"BFnrneph201760_CR43","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00281-010-0230-z","volume":"33","author":"EE Golub","year":"2011","unstructured":"Golub, E. E. Biomineralization and matrix vesicles in biology and pathology. Semin. Immunopathol. 33, 409\u2013417 (2011).","journal-title":"Semin. Immunopathol."},{"key":"BFnrneph201760_CR44","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1161\/CIRCRESAHA.113.301036","volume":"113","author":"SE New","year":"2013","unstructured":"New, S. E. et al. Macrophage-derived matrix vesicles: an alternative novel mechanism for microcalcification in atherosclerotic plaques. Circ. Res. 113, 72\u201377 (2013).","journal-title":"Circ. Res."},{"key":"BFnrneph201760_CR45","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1161\/CIRCULATIONAHA.113.005015","volume":"129","author":"S Allahverdian","year":"2014","unstructured":"Allahverdian, S., Chehroudi, A. C., McManus, B. M., Abraham, T. & Francis, G. A. Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis. Circulation 129, 1551\u20131559 (2014).","journal-title":"Circulation"},{"key":"BFnrneph201760_CR46","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.stem.2016.08.001","volume":"19","author":"R Kramann","year":"2016","unstructured":"Kramann, R. et al. Adventitial msc-like cells are progenitors of vascular smooth muscle cells and drive vascular calcification in chronic kidney disease. Cell Stem Cell 19, 628\u2013642 (2016).","journal-title":"Cell Stem Cell"},{"key":"BFnrneph201760_CR47","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1359\/jbmr.080604","volume":"23","author":"N Chen","year":"2008","unstructured":"Chen, N., O'Neill, K., Chen, X. & Moe, S. Annexin-mediated matrix vesicle calcification in vascular smooth muscle cells. J. Bone Miner. Res. 23, 1798\u20131805 (2008).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrneph201760_CR48","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00223-012-9672-8","volume":"93","author":"JL Millan","year":"2013","unstructured":"Millan, J. L. The role of phosphatases in the initiation of skeletal mineralization. Calcif. Tissue Int. 93, 299\u2013306 (2013).","journal-title":"Calcif. Tissue Int."},{"key":"BFnrneph201760_CR49","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1073\/pnas.67.3.1513","volume":"67","author":"SY Ali","year":"1970","unstructured":"Ali, S. Y., Sajdera, S. W. & Anderson, H. C. Isolation and characterization of calcifying matrix vesicles from epiphyseal cartilage. Proc. Natl Acad. Sci. USA 67, 1513\u20131520 (1970).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201760_CR50","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/ki.2012.482","volume":"83","author":"XY Dai","year":"2013","unstructured":"Dai, X. Y. et al. Phosphate-induced autophagy counteracts vascular calcification by reducing matrix vesicle release. Kidney Int. 83, 1042\u20131051 (2013).","journal-title":"Kidney Int."},{"key":"BFnrneph201760_CR51","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1172\/JCI80851","volume":"126","author":"C Goettsch","year":"2016","unstructured":"Goettsch, C. et al. Sortilin mediates vascular calcification via its recruitment into extracellular vesicles. J. Clin. Invest. 126, 1323\u20131336 (2016).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201760_CR52","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1152\/ajplegacy.1961.200.6.1296","volume":"200","author":"H Fleish","year":"1961","unstructured":"Fleish, H. & Neuman, W. F. Mechanisms of calcification: role of collagen, polyphosphates, and phosphatase. Am. J. Physiol. 200, 1296\u20131300 (1961).","journal-title":"Am. J. Physiol."},{"key":"BFnrneph201760_CR53","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/195911a0","volume":"195","author":"H Fleisch","year":"1962","unstructured":"Fleisch, H. & Bisaz, S. Mechanism of calcification: inhibitory role of pyrophosphate. Nature 195, 911 (1962).","journal-title":"Nature"},{"key":"BFnrneph201760_CR54","doi-asserted-by":"publisher","first-page":"9445","DOI":"10.1073\/pnas.142063399","volume":"99","author":"L Hessle","year":"2002","unstructured":"Hessle, L. et al. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc. Natl Acad. Sci. USA 99, 9445\u20139449 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201760_CR55","doi-asserted-by":"publisher","first-page":"20197","DOI":"10.1074\/jbc.M909174199","volume":"275","author":"S Jono","year":"2000","unstructured":"Jono, S., Peinado, C. & Giachelli, C. Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification. J. Biol. Chem. 275, 20197\u201320203 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201760_CR56","doi-asserted-by":"publisher","unstructured":"Halling Linder, C. et al. Bone alkaline phosphatase and tartrate-resistant acid phosphatase: potential co-regulators of bone mineralization. Calcif. Tissue Int. http:\/\/dx.doi.org\/10.1007\/s00223-017-0259-2 (2017).","DOI":"10.1007\/s00223-017-0259-2"},{"key":"BFnrneph201760_CR57","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1042\/bj0170286","volume":"17","author":"R Robison","year":"1923","unstructured":"Robison, R. The possible significance of hexosephosphoric esters in ossification. Biochem. J. 17, 286\u2013293 (1923).","journal-title":"Biochem. J."},{"key":"BFnrneph201760_CR58","doi-asserted-by":"publisher","unstructured":"Villa-Bellosta, R. & Egido, J. Phosphate, pyrophosphate, and vascular calcification: a question of balance. Eur. Heart J. http:\/\/dx.doi.org\/10.1093\/eurheartj\/ehv605 (2015).","DOI":"10.1093\/eurheartj\/ehv605"},{"key":"BFnrneph201760_CR59","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/ki.2013.521","volume":"85","author":"KA Lomashvili","year":"2014","unstructured":"Lomashvili, K. A., Narisawa, S., Millan, J. L. & O'Neill, W. C. Vascular calcification is dependent on plasma levels of pyrophosphate. Kidney Int. 85, 1351\u20131356 (2014).","journal-title":"Kidney Int."},{"key":"BFnrneph201760_CR60","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/ki.2014.372","volume":"87","author":"RA de Oliveira","year":"2015","unstructured":"de Oliveira, R. A. et al. Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease. Kidney Int. 87, 1039\u20131045 (2015).","journal-title":"Kidney Int."},{"key":"BFnrneph201760_CR61","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/jbmr.2606","volume":"31","author":"SK Murali","year":"2016","unstructured":"Murali, S. K. et al. Fgf23 regulates bone mineralization in a 1,25(OH)2D3 and Klotho-independent manner. J. Bone Miner. Res. 31, 129\u2013142 (2016).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrneph201760_CR62","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1172\/JCI45890","volume":"122","author":"L Lieben","year":"2012","unstructured":"Lieben, L. et al. Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization. J. Clin. Invest. 122, 1803\u20131815 (2012).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201760_CR63","doi-asserted-by":"publisher","first-page":"H61","DOI":"10.1152\/ajpheart.01020.2010","volume":"301","author":"R Villa-Bellosta","year":"2011","unstructured":"Villa-Bellosta, R., Wang, X., Millan, J. L., Dubyak, G. R. & O'Neill, W. C. Extracellular pyrophosphate metabolism and calcification in vascular smooth muscle. Am. J. Physiol. Heart Circ. Physiol. 301, H61\u2013H68 (2011).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrneph201760_CR64","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1046\/j.1523-1755.2002.00170.x","volume":"61","author":"S Moe","year":"2002","unstructured":"Moe, S. et al. Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int. 61, 638\u2013647 (2002).","journal-title":"Kidney Int."},{"key":"BFnrneph201760_CR65","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1161\/CIRCULATIONAHA.108.783738","volume":"118","author":"R Shroff","year":"2008","unstructured":"Shroff, R. et al. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 118, 1748\u20131757 (2008).","journal-title":"Circulation"},{"key":"BFnrneph201760_CR66","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1161\/01.CIR.100.21.2168","volume":"100","author":"C Shanahan","year":"1999","unstructured":"Shanahan, C. et al. Medial localization of mineralization-regulating proteins in association with m\u00f6nckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation 100, 2168\u20132176 (1999).","journal-title":"Circulation"},{"key":"BFnrneph201760_CR67","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11892-003-0049-2","volume":"3","author":"N Chen","year":"2003","unstructured":"Chen, N. & Moe, S. Arterial calcification in diabetes. Curr. Diab. Rep. 3, 28\u201332 (2003).","journal-title":"Curr. Diab. Rep."},{"key":"BFnrneph201760_CR68","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1056\/NEJMoa0912923","volume":"364","author":"C St Hilaire","year":"2011","unstructured":"St Hilaire, C. et al. Nt5e mutations and arterial calcifications. N. Engl. J. Med. 364, 432\u2013442 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201760_CR69","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1161\/CIRCULATIONAHA.112.000571","volume":"127","author":"R Villa-Bellosta","year":"2013","unstructured":"Villa-Bellosta, R. et al. Defective extracellular pyrophosphate metabolism promotes vascular calcification in a mouse model of Hutchinson\u2013Gilford progeria syndrome that is ameliorated on pyrophosphate treatment. Circulation 127, 2442\u20132451 (2013).","journal-title":"Circulation"},{"key":"BFnrneph201760_CR70","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/jbmr.2420","volume":"30","author":"CR Sheen","year":"2015","unstructured":"Sheen, C. R. et al. Pathophysiological role of vascular smooth muscle alkaline phosphatase in medial artery calcification. J. Bone Miner. Res. 30, 824\u2013836 (2015).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrneph201760_CR71","doi-asserted-by":"publisher","first-page":"e002499","DOI":"10.1161\/JAHA.115.002499","volume":"4","author":"AY Savinov","year":"2015","unstructured":"Savinov, A. Y. et al. Transgenic overexpression of tissue-nonspecific alkaline phosphatase (TNAP) in vascular endothelium results in generalized arterial calcification. J. Am. Heart Assoc. 4, e002499 (2015).","journal-title":"J. Am. Heart Assoc."},{"key":"BFnrneph201760_CR72","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s11914-015-0293-9","volume":"13","author":"NX Chen","year":"2015","unstructured":"Chen, N. X. & Moe, S. M. Pathophysiology of vascular calcification. Curr. Osteoporos. Rep. 13, 372\u2013380 (2015).","journal-title":"Curr. Osteoporos. Rep."},{"key":"BFnrneph201760_CR73","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1093\/ndt\/gfn686","volume":"24","author":"F Graciolli","year":"2009","unstructured":"Graciolli, F. et al. Phosphorus overload and PTH induce aortic expression of Runx2 in experimental uraemia. Nephrol. Dial. Transplant. 24, 1416\u20131421 (2009).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201760_CR74","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1053\/j.ajkd.2010.08.037","volume":"57","author":"N Tangri","year":"2011","unstructured":"Tangri, N. et al. Effect of bone mineral guideline target achievement on mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry. Am. J. Kidney Dis. 57, 415\u2013421 (2011).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201760_CR75","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1053\/j.ajkd.2013.02.366","volume":"62","author":"S Sardiwal","year":"2013","unstructured":"Sardiwal, S., Magnusson, P., Goldsmith, D. J. & Lamb, E. J. Bone alkaline phosphatase in CKD-mineral bone disorder. Am. J. Kidney Dis. 62, 810\u2013822 (2013).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201760_CR76","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1001\/jama.2011.308","volume":"305","author":"SC Palmer","year":"2011","unstructured":"Palmer, S. C. et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 305, 1119\u20131127 (2011).","journal-title":"JAMA"},{"key":"BFnrneph201760_CR77","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1359\/jbmr.080610","volume":"23","author":"A Fahrleitner-Pammer","year":"2008","unstructured":"Fahrleitner-Pammer, A. et al. Bone markers predict cardiovascular events in chronic kidney disease. J. Bone Miner. Res. 23, 1850\u20131858 (2008).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrneph201760_CR78","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/ki.2010.356","volume":"79","author":"S Damera","year":"2011","unstructured":"Damera, S. et al. Serum alkaline phosphatase levels associate with elevated serum c-reactive protein in chronic kidney disease. Kidney Int. 79, 228\u2013233 (2011).","journal-title":"Kidney Int."},{"key":"BFnrneph201760_CR79","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3109\/1354750X.2010.509811","volume":"15","author":"F Nayeem","year":"2010","unstructured":"Nayeem, F., Anderson, K. E., Nagamani, M., Grady, J. J. & Lu, L. J. Alkaline phosphatase and percentage body fat predict circulating c-reactive protein in premenopausal women. Biomarkers 15, 663\u2013670 (2010).","journal-title":"Biomarkers"},{"key":"BFnrneph201760_CR80","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1053\/j.jrn.2008.11.004","volume":"19","author":"CT Lee","year":"2009","unstructured":"Lee, C. T. et al. Association between c-reactive protein and biomarkers of bone and mineral metabolism in chronic hemodialysis patients: a cross-sectional study. J. Ren. Nutr. 19, 220\u2013227 (2009).","journal-title":"J. Ren. Nutr."},{"key":"BFnrneph201760_CR81","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1515\/CCLM.2008.111","volume":"46","author":"BM Cheung","year":"2008","unstructured":"Cheung, B. M. et al. Association between plasma alkaline phosphatase and c-reactive protein in Hong Kong Chinese. Clin. Chem. Lab. Med. 46, 523\u2013527 (2008).","journal-title":"Clin. Chem. Lab. Med."},{"key":"BFnrneph201760_CR82","doi-asserted-by":"publisher","first-page":"e0132822","DOI":"10.1371\/journal.pone.0132822","volume":"10","author":"SK Kunutsor","year":"2015","unstructured":"Kunutsor, S. K. et al. Serum alkaline phosphatase and risk of incident cardiovascular disease: interrelationship with high sensitivity c-reactive protein. PLoS ONE 10, e0132822 (2015).","journal-title":"PLoS ONE"},{"key":"BFnrneph201760_CR83","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2215\/CJN.12031111","volume":"8","author":"R Filipowicz","year":"2013","unstructured":"Filipowicz, R. et al. Associations of serum skeletal alkaline phosphatase with elevated c-reactive protein and mortality. Clin. J. Am. Soc. Nephrol. 8, 26\u201332 (2013).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201760_CR84","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1161\/ATVBAHA.112.300826","volume":"33","author":"SG Wannamethee","year":"2013","unstructured":"Wannamethee, S. G., Sattar, N., Papcosta, O., Lennon, L. & Whincup, P. H. Alkaline phosphatase, serum phosphate, and incident cardiovascular disease and total mortality in older men. Arterioscler. Thromb. Vasc. Biol. 33, 1070\u20131076 (2013).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrneph201760_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lfs.2015.12.021","volume":"145","author":"IJ Cho","year":"2016","unstructured":"Cho, I. J. et al. Effects of c-reactive protein on bone cells. Life Sci. 145, 1\u20138 (2016).","journal-title":"Life Sci."},{"key":"BFnrneph201760_CR86","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.bone.2010.09.001","volume":"48","author":"P Lencel","year":"2011","unstructured":"Lencel, P., Delplace, S., Hardouin, P. & Magne, D. TNF-\u03b1 stimulates alkaline phosphatase and mineralization through PPAR\u03b3 inhibition in human osteoblasts. Bone 48, 242\u2013249 (2011).","journal-title":"Bone"},{"key":"BFnrneph201760_CR87","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.atherosclerosis.2016.05.044","volume":"251","author":"P Aghagolzadeh","year":"2016","unstructured":"Aghagolzadeh, P. et al. Calcification of vascular smooth muscle cells is induced by secondary calciprotein particles and enhanced by tumor necrosis factor-alpha. Atherosclerosis 251, 404\u2013414 (2016).","journal-title":"Atherosclerosis"},{"key":"BFnrneph201760_CR88","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.arcmed.2006.05.016","volume":"38","author":"LN Shanmugham","year":"2007","unstructured":"Shanmugham, L. N. et al. Il-1beta induces alkaline phosphatase in human phagocytes. Arch. Med. Res. 38, 39\u201344 (2007).","journal-title":"Arch. Med. Res."},{"key":"BFnrneph201760_CR89","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/B978-0-12-385526-8.00009-6","volume":"61","author":"F Kukulski","year":"2011","unstructured":"Kukulski, F., Levesque, S. A. & Sevigny, J. Impact of ectoenzymes on p2 and p1 receptor signaling. Adv. Pharmacol. 61, 263\u2013299 (2011).","journal-title":"Adv. Pharmacol."},{"key":"BFnrneph201760_CR90","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molmed.2013.03.005","volume":"19","author":"L Antonioli","year":"2013","unstructured":"Antonioli, L., Pacher, P., Vizi, E. S. & Hasko, G. Cd39 and cd73 in immunity and inflammation. Trends Mol. Med. 19, 355\u2013367 (2013).","journal-title":"Trends Mol. Med."},{"key":"BFnrneph201760_CR91","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jss.2015.12.008","volume":"202","author":"J Fawley","year":"2016","unstructured":"Fawley, J. & Gourlay, D. M. Intestinal alkaline phosphatase: a summary of its role in clinical disease. J. Surg. Res. 202, 225\u2013234 (2016).","journal-title":"J. Surg. Res."},{"key":"BFnrneph201760_CR92","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/jemt.10156","volume":"58","author":"T Okada","year":"2002","unstructured":"Okada, T., Zinchuk, V. S. & Seguchi, H. Lipopolysaccharide administration increases acid and alkaline phosphatase reactivity in the cardiac muscle. Microsc. Res. Tech. 58, 421\u2013426 (2002).","journal-title":"Microsc. Res. Tech."},{"key":"BFnrneph201760_CR93","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.bbadis.2013.07.016","volume":"1832","author":"AF Pike","year":"2013","unstructured":"Pike, A. F., Kramer, N. I., Blaauboer, B. J., Seinen, W. & Brands, R. A novel hypothesis for an alkaline phosphatase 'rescue' mechanism in the hepatic acute phase immune response. Biochim. Biophys. Acta 1832, 2044\u20132056 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrneph201760_CR94","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1161\/CIRCRESAHA.116.305715","volume":"116","author":"J Jalkanen","year":"2015","unstructured":"Jalkanen, J. et al. Aberrant circulating levels of purinergic signaling markers are associated with several key aspects of peripheral atherosclerosis and thrombosis. Circ. Res. 116, 1206\u20131215 (2015).","journal-title":"Circ. Res."},{"key":"BFnrneph201760_CR95","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.atherosclerosis.2016.12.014","volume":"257","author":"S Qian","year":"2017","unstructured":"Qian, S. et al. The P2Y2 nucleotide receptor is an inhibitor of vascular calcification. Atherosclerosis 257, 38\u201346 (2017).","journal-title":"Atherosclerosis"},{"key":"BFnrneph201760_CR96","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/nure.12082","volume":"72","author":"JP Lalles","year":"2014","unstructured":"Lalles, J. P. Intestinal alkaline phosphatase: novel functions and protective effects. Nutr. Rev. 72, 82\u201394 (2014).","journal-title":"Nutr. Rev."},{"key":"BFnrneph201760_CR97","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/0016-5085(88)90610-5","volume":"94","author":"DH Alpers","year":"1988","unstructured":"Alpers, D. H. et al. Intestinal alkaline phosphatase in patients with chronic renal failure. Gastroenterology 94, 62\u201367 (1988).","journal-title":"Gastroenterology"},{"key":"BFnrneph201760_CR98","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S0140-6736(74)92980-8","volume":"303","author":"ME De Broe","year":"1974","unstructured":"De Broe, M. E., Bosteels, V. & Wieme, R. J. Letter: increased intestinal alkaline phosphatase in serum of patients on maintenance haemodialysis. Lancet 303, 753\u2013754 (1974).","journal-title":"Lancet"},{"key":"BFnrneph201760_CR99","first-page":"75","volume":"78","author":"J Stepan","year":"1977","unstructured":"Stepan, J., Pilarova, T. & Melicharova, D. The source and clinical significance of serum alkaline phosphatases in patients treated by chronic dialysis. Acta Univ. Carol. Med. Monogr. 78, 75\u201379 (1977).","journal-title":"Acta Univ. Carol. Med. Monogr."},{"key":"BFnrneph201760_CR100","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/clinchem\/37.6.815","volume":"37","author":"L Tibi","year":"1991","unstructured":"Tibi, L., Chhabra, S. C., Sweeting, V. M., Winney, R. J. & Smith, A. F. Multiple forms of alkaline phosphatase in plasma of hemodialysis patients. Clin. Chem. 37, 815\u2013820 (1991).","journal-title":"Clin. Chem."},{"key":"BFnrneph201760_CR101","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1373\/clinchem.2004.045831","volume":"51","author":"H Zetterberg","year":"2005","unstructured":"Zetterberg, H. Increased serum concentrations of intestinal alkaline phosphatase in peritoneal dialysis. Clin. Chem. 51, 675\u2013676 (2005).","journal-title":"Clin. Chem."},{"key":"BFnrneph201760_CR102","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1053\/j.ajkd.2009.06.022","volume":"54","author":"DS Raj","year":"2009","unstructured":"Raj, D. S. et al. Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients. Am. J. Kidney Dis. 54, 1072\u20131080 (2009).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201760_CR103","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1681\/ASN.2015111285","volume":"28","author":"K Andersen","year":"2016","unstructured":"Andersen, K. et al. Intestinal dysbiosis, barrier dysfunction, and bacterial translocation account for CKD-related systemic inflammation. J. Am. Soc. Nephrol. 28, 76\u201383 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201760_CR104","doi-asserted-by":"publisher","first-page":"F857","DOI":"10.1152\/ajprenal.00513.2015","volume":"310","author":"DA Kieffer","year":"2016","unstructured":"Kieffer, D. A. et al. Resistant starch alters gut microbiome and metabolomic profiles concurrent with amelioration of chronic kidney disease in rats. Am. J. Physiol. Renal Physiol. 310, F857\u2013F871 (2016).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201760_CR105","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1136\/gut.2010.211706","volume":"59","author":"MS Malo","year":"2010","unstructured":"Malo, M. S. et al. Intestinal alkaline phosphatase preserves the normal homeostasis of gut microbiota. Gut 59, 1476\u20131484 (2010).","journal-title":"Gut"},{"key":"BFnrneph201760_CR106","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/BF02017639","volume":"6","author":"B Aronsson","year":"1987","unstructured":"Aronsson, B., Barany, P., Nord, C. E., Nystrom, B. & Stenvinkel, P. Clostridium difficile-associated diarrhoea in uremic patients. Eur. J. Clin. Microbiol. 6, 352\u2013356 (1987).","journal-title":"Eur. J. Clin. Microbiol."},{"key":"BFnrneph201760_CR107","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/SLA.0b013e31828fae14","volume":"259","author":"SN Alam","year":"2014","unstructured":"Alam, S. N. et al. Intestinal alkaline phosphatase prevents antibiotic-induced susceptibility to enteric pathogens. Ann. Surg. 259, 715\u2013722 (2014).","journal-title":"Ann. Surg."},{"key":"BFnrneph201760_CR108","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/MNH.0b013e32835dda78","volume":"22","author":"AK Singh","year":"2013","unstructured":"Singh, A. K. & Kari, J. A. Metabolic syndrome and chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 22, 198\u2013203 (2013).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"BFnrneph201760_CR109","doi-asserted-by":"publisher","first-page":"7003","DOI":"10.1073\/pnas.1220180110","volume":"110","author":"K Kaliannan","year":"2013","unstructured":"Kaliannan, K. et al. Intestinal alkaline phosphatase prevents metabolic syndrome in mice. Proc. Natl Acad. Sci. USA 110, 7003\u20137008 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201760_CR110","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1016\/j.ebiom.2015.11.027","volume":"2","author":"MS Malo","year":"2015","unstructured":"Malo, M. S. A high level of intestinal alkaline phosphatase is protective against type 2 diabetes mellitus irrespective of obesity. EBioMedicine 2, 2016\u20132023 (2015).","journal-title":"EBioMedicine"},{"key":"BFnrneph201760_CR111","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1177\/41.12.8245430","volume":"41","author":"S Schultz-Hector","year":"1993","unstructured":"Schultz-Hector, S., Balz, K., Bohm, M., Ikehara, Y. & Rieke, L. Cellular localization of endothelial alkaline phosphatase reaction product and enzyme protein in the myocardium. J. Histochem. Cytochem. 41, 1813\u20131821 (1993).","journal-title":"J. Histochem. Cytochem."},{"key":"BFnrneph201760_CR112","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-94-017-7197-9_7","volume":"76","author":"B Deracinois","year":"2015","unstructured":"Deracinois, B., Lenfant, A. M., Dehouck, M. P. & Flahaut, C. Tissue non-specific alkaline phosphatase (TNAP) in vessels of the brain. Subcell. Biochem. 76, 125\u2013151 (2015).","journal-title":"Subcell. Biochem."},{"key":"BFnrneph201760_CR113","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1161\/CIRCRESAHA.111.300543","volume":"112","author":"Y Liu","year":"2013","unstructured":"Liu, Y., Drozdov, I., Shroff, R., Beltran, L. E. & Shanahan, C. M. Prelamin A accelerates vascular calcification via activation of the DNA damage response and senescence-associated secretory phenotype in vascular smooth muscle cells. Circ. Res. 112, e99\u2013e109 (2013).","journal-title":"Circ. Res."},{"key":"BFnrneph201760_CR114","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1161\/STROKEAHA.115.010835","volume":"47","author":"Y Yamazaki","year":"2016","unstructured":"Yamazaki, Y. et al. Vascular cell senescence contributes to blood-brain barrier breakdown. Stroke 47, 1068\u20131077 (2016).","journal-title":"Stroke"},{"key":"BFnrneph201760_CR115","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cbi.2014.12.006","volume":"226","author":"AF Pike","year":"2015","unstructured":"Pike, A. F., Kramer, N. I., Blaauboer, B. J., Seinen, W. & Brands, R. An alkaline phosphatase transport mechanism in the pathogenesis of Alzheimer's disease and neurodegeneration. Chem. Biol. Interact. 226, 30\u201339 (2015).","journal-title":"Chem. Biol. Interact."},{"key":"BFnrneph201760_CR116","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1161\/HYPERTENSIONAHA.115.06117","volume":"66","author":"F Perticone","year":"2015","unstructured":"Perticone, F. et al. Serum alkaline phosphatase negatively affects endothelium-dependent vasodilation in naive hypertensive patients. Hypertension 66, 874\u2013880 (2015).","journal-title":"Hypertension"},{"key":"BFnrneph201760_CR117","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0891-5849(01)00610-4","volume":"31","author":"N Mody","year":"2001","unstructured":"Mody, N., Parhami, F., Sarafian, T. & Demer, L. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic. Biol. Med. 31, 509\u2013519 (2001).","journal-title":"Free Radic. Biol. Med."},{"key":"BFnrneph201760_CR118","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1093\/ndt\/gfn757","volume":"24","author":"G Muteliefu","year":"2009","unstructured":"Muteliefu, G., Enomoto, A., Jiang, P., Takahashi, M. & Niwa, T. Indoxyl sulphate induces oxidative stress and the expression of osteoblast-specific proteins in vascular smooth muscle cells. Nephrol. Dial. Transplant. 24, 2051\u20132058 (2009).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201760_CR119","doi-asserted-by":"publisher","first-page":"e00092","DOI":"10.1002\/prp2.92","volume":"3","author":"H Watanabe","year":"2015","unstructured":"Watanabe, H. et al. P-cresyl sulfate, a uremic toxin, causes vascular endothelial and smooth muscle cell damages by inducing oxidative stress. Pharmacol. Res. Perspect. 3, e00092 (2015).","journal-title":"Pharmacol. Res. Perspect."},{"key":"BFnrneph201760_CR120","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/jcb.25752","volume":"118","author":"G Raghuraman","year":"2017","unstructured":"Raghuraman, G. et al. Eotaxin augments calcification in vascular smooth muscle cells. J. Cell. Biochem. 118, 647\u2013654 (2017).","journal-title":"J. Cell. Biochem."},{"key":"BFnrneph201760_CR121","doi-asserted-by":"publisher","first-page":"8490643","DOI":"10.1155\/2016\/8490643","volume":"2016","author":"C Torino","year":"2016","unstructured":"Torino, C. et al. Oxidative stress as estimated by gamma-glutamyl transferase levels amplifies the alkaline phosphatase-dependent risk for mortality in ESKD patients on dialysis. Oxid. Med. Cell. Longev. 2016, 8490643 (2016).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"BFnrneph201760_CR122","doi-asserted-by":"publisher","first-page":"e0122921","DOI":"10.1371\/journal.pone.0122921","volume":"10","author":"SW Oh","year":"2015","unstructured":"Oh, S. W., Han, K. H. & Han, S. Y. Associations between renal hyperfiltration and serum alkaline phosphatase. PLoS ONE 10, e0122921 (2015).","journal-title":"PLoS ONE"},{"key":"BFnrneph201760_CR123","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3109\/0886022X.2013.872569","volume":"36","author":"T Bulum","year":"2014","unstructured":"Bulum, T., Kolaric, B., Duvnjak, M. & Duvnjak, L. Alkaline phosphatase is independently associated with renal function in normoalbuminuric type 1 diabetic patients. Ren. Fail. 36, 372\u2013377 (2014).","journal-title":"Ren. Fail."},{"key":"BFnrneph201760_CR124","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/ki.1980.28","volume":"17","author":"G Pfleiderer","year":"1980","unstructured":"Pfleiderer, G. et al. Change in alkaline phosphatase isoenzyme pattern in urine as possible marker for renal disease. Kidney Int. 17, 242\u2013249 (1980).","journal-title":"Kidney Int."},{"key":"BFnrneph201760_CR125","doi-asserted-by":"publisher","first-page":"e75547","DOI":"10.1371\/journal.pone.0075547","volume":"8","author":"A Tobar","year":"2013","unstructured":"Tobar, A. et al. Proximal tubular hypertrophy and enlarged glomerular and proximal tubular urinary space in obese subjects with proteinuria. PLoS ONE 8, e75547 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrneph201760_CR126","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.nut.2011.03.003","volume":"28","author":"BK Canales","year":"2012","unstructured":"Canales, B. K. et al. Renal glomerular and tubular injury after gastric bypass in obese rats. Nutrition 28, 76\u201380 (2012).","journal-title":"Nutrition"},{"key":"BFnrneph201760_CR127","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1046\/j.1365-2613.2003.00345.x","volume":"84","author":"JJ Kapojos","year":"2003","unstructured":"Kapojos, J. J. et al. Induction of glomerular alkaline phosphatase after challenge with lipopolysaccharide. Int. J. Exp. Pathol. 84, 135\u2013144 (2003).","journal-title":"Int. J. Exp. Pathol."},{"key":"BFnrneph201760_CR128","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0065-1281(83)80032-4","volume":"73","author":"N Briere","year":"1983","unstructured":"Briere, N., Petitclerc, C. & Plante, G. Presence of alkaline phosphatase and gamma-glutamyl transpeptidase on the parietal layer of Bowman's capsule. Acta Histochem. 73, 237\u2013241 (1983).","journal-title":"Acta Histochem."},{"key":"BFnrneph201760_CR129","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/BF00217408","volume":"234","author":"N Briere","year":"1983","unstructured":"Briere, N., Plante, G. E. & Petitclerc, C. Electron-microscopic demonstration of alkaline-phosphatase activity in the juxtaglomerular apparatus. Cell. Tissue Res. 234, 147\u2013151 (1983).","journal-title":"Cell. Tissue Res."},{"key":"BFnrneph201760_CR130","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrendo.2016.14","volume":"12","author":"MP Whyte","year":"2016","unstructured":"Whyte, M. P. Hypophosphatasia \u2014 aetiology, nosology, pathogenesis, diagnosis and treatment. Nat. Rev. Endocrinol. 12, 233\u2013246 (2016).","journal-title":"Nat. Rev. Endocrinol."},{"key":"BFnrneph201760_CR131","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.atherosclerosis.2014.06.006","volume":"236","author":"SK Kunutsor","year":"2014","unstructured":"Kunutsor, S. K., Apekey, T. A. & Khan, H. Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies. Atherosclerosis 236, 7\u201317 (2014).","journal-title":"Atherosclerosis"},{"key":"BFnrneph201760_CR132","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.cca.2013.08.009","volume":"425","author":"MP Iqbal","year":"2013","unstructured":"Iqbal, M. P., Mehboobali, N., Azam, I. & Tareen, A. K. Association of alkaline phosphatase with acute myocardial infarction in a population with high prevalence of hypovitaminosis D. Clin. Chim. Acta 425, 192\u2013195 (2013).","journal-title":"Clin. Chim. Acta"},{"key":"BFnrneph201760_CR133","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/eurheartj\/ehs419","volume":"34","author":"JB Park","year":"2013","unstructured":"Park, J. B. et al. Serum alkaline phosphatase is a predictor of mortality, myocardial infarction, or stent thrombosis after implantation of coronary drug-eluting stent. Eur. Heart J. 34, 920\u2013931 (2013).","journal-title":"Eur. Heart J."},{"key":"BFnrneph201760_CR134","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.2215\/CJN.06091108","volume":"4","author":"R Shantouf","year":"2009","unstructured":"Shantouf, R. et al. Association of serum alkaline phosphatase with coronary artery calcification in maintenance hemodialysis patients. Clin. J. Am. Soc. Nephrol. 4, 1106\u20131114 (2009).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201760_CR135","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1097\/01.ASN.0000129337.50739.48","volume":"15","author":"G London","year":"2004","unstructured":"London, G. et al. Arterial calcifications and bone histomorphometry in end-stage renal disease. J. Am. Soc. Nephrol. 15, 1943\u20131951 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201760_CR136","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1053\/j.ajkd.2008.06.024","volume":"52","author":"DV Barreto","year":"2008","unstructured":"Barreto, D. V. et al. Association of changes in bone remodeling and coronary calcification in hemodialysis patients: a prospective study. Am. J. Kidney Dis. 52, 1139\u20131150 (2008).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201760_CR137","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/ki.1994.342","volume":"46","author":"P Kurz","year":"1994","unstructured":"Kurz, P. et al. Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int. 46, 855\u2013861 (1994).","journal-title":"Kidney Int."},{"key":"BFnrneph201760_CR138","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.semnephrol.2014.09.008","volume":"34","author":"J Bover","year":"2014","unstructured":"Bover, J. et al. Adynamic bone disease: from bone to vessels in chronic kidney disease. Semin. Nephrol. 34, 626\u2013640 (2014).","journal-title":"Semin. Nephrol."},{"key":"BFnrneph201760_CR139","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/ndt\/gfp373","volume":"25","author":"M Briet","year":"2010","unstructured":"Briet, M. et al. Age-independent association between arterial and bone remodeling in mild-to-moderate chronic kidney disease. Nephrol. Dial. Transplant. 25, 191\u2013197 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201760_CR140","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/ki.2008.26","volume":"73","author":"K Lomashvili","year":"2008","unstructured":"Lomashvili, K., Garg, P., Narisawa, S., Millan, J. & O'Neill, W. Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification. Kidney Int. 73, 1024\u20131030 (2008).","journal-title":"Kidney Int."},{"key":"BFnrneph201760_CR141","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1681\/ASN.2004080694","volume":"16","author":"K Lomashvili","year":"2005","unstructured":"Lomashvili, K., Khawandi, W. & O'Neill, W. Reduced plasma pyrophosphate levels in hemodialysis patients. J. Am. Soc. Nephrol. 16, 2495\u20132500 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201760_CR142","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/ki.2010.461","volume":"79","author":"WC O'Neill","year":"2011","unstructured":"O'Neill, W. C., Lomashvili, K. A., Malluche, H. H., Faugere, M. C. & Riser, B. L. Treatment with pyrophosphate inhibits uremic vascular calcification. Kidney Int. 79, 512\u2013517 (2011).","journal-title":"Kidney Int."},{"key":"BFnrneph201760_CR143","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1161\/CIRCULATIONAHA.109.851873","volume":"120","author":"M Tonelli","year":"2009","unstructured":"Tonelli, M. et al. Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortality. Circulation 120, 1784\u20131792 (2009).","journal-title":"Circulation"},{"key":"BFnrneph201760_CR144","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/sj.ki.5001514","volume":"70","author":"K Kalantar-Zadeh","year":"2006","unstructured":"Kalantar-Zadeh, K. et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int. 70, 771\u2013780 (2006).","journal-title":"Kidney Int."},{"key":"BFnrneph201760_CR145","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1681\/ASN.2008010014","volume":"19","author":"D Regidor","year":"2008","unstructured":"Regidor, D. et al. Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J. Am. Soc. Nephrol. 19, 2193\u20132203 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201760_CR146","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/ki.2008.248","volume":"74","author":"MJ Blayney","year":"2008","unstructured":"Blayney, M. J. et al. High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death. Kidney Int. 74, 655\u2013663 (2008).","journal-title":"Kidney Int."},{"key":"BFnrneph201760_CR147","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.2215\/CJN.01560309","volume":"4","author":"S Beddhu","year":"2009","unstructured":"Beddhu, S., Ma, X., Baird, B., Cheung, A. & Greene, T. Serum alkaline phosphatase and mortality in African Americans with chronic kidney disease. Clin. J. Am. Soc. Nephrol. 4, 1805\u20131810 (2009).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201760_CR148","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1093\/ndt\/gfq144","volume":"25","author":"CP Kovesdy","year":"2010","unstructured":"Kovesdy, C. P., Ureche, V., Lu, J. L. & Kalantar-Zadeh, K. Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD. Nephrol. Dial. Transplant. 25, 3003\u20133011 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201760_CR149","doi-asserted-by":"publisher","first-page":"91","DOI":"10.5414\/CNP74091","volume":"74","author":"S Beddhu","year":"2010","unstructured":"Beddhu, S., Baird, B., Ma, X., Cheung, A. K. & Greene, T. Serum alkaline phosphatase and mortality in hemodialysis patients. Clin. Nephrol. 74, 91\u201396 (2010).","journal-title":"Clin. Nephrol."},{"key":"BFnrneph201760_CR150","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1093\/ndt\/gfr747","volume":"27","author":"LR Lukowsky","year":"2012","unstructured":"Lukowsky, L. R. et al. Mineral and bone disorders and survival in hemodialysis patients with and without polycystic kidney disease. Nephrol. Dial. Transplant. 27, 2899\u20132907 (2012).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201760_CR151","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3747\/pdi.2013.00110","volume":"34","author":"CM Rhee","year":"2014","unstructured":"Rhee, C. M. et al. Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis. Perit. Dial. Int. 34, 732\u2013748 (2014).","journal-title":"Perit. Dial. Int."},{"key":"BFnrneph201760_CR152","doi-asserted-by":"publisher","first-page":"771","DOI":"10.2215\/CJN.08280813","volume":"9","author":"X Liu","year":"2014","unstructured":"Liu, X. et al. Alkaline phosphatase and mortality in patients on peritoneal dialysis. Clin. J. Am. Soc. Nephrol. 9, 771\u2013778 (2014).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201760_CR153","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1093\/ndt\/gfu055","volume":"29","author":"Y Maruyama","year":"2014","unstructured":"Maruyama, Y. et al. A higher serum alkaline phosphatase is associated with the incidence of hip fracture and mortality among patients receiving hemodialysis in Japan. Nephrol. Dial. Transplant. 29, 1532\u20131538 (2014).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201760_CR154","first-page":"61","volume":"29","author":"PA Fein","year":"2013","unstructured":"Fein, P. A. et al. Relationship between alkaline phosphatase and all-cause mortality in peritoneal dialysis patients. Adv. Perit. Dial. 29, 61\u201363 (2013).","journal-title":"Adv. Perit. Dial."},{"key":"BFnrneph201760_CR155","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1093\/ndt\/gft290","volume":"28","author":"P Lertdumrongluk","year":"2013","unstructured":"Lertdumrongluk, P. et al. Impact of age on survival predictability of bone turnover markers in hemodialysis patients. Nephrol. Dial. Transplant. 28, 2535\u20132545 (2013).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201760_CR156","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1053\/j.ajkd.2013.04.012","volume":"62","author":"JJ Taliercio","year":"2013","unstructured":"Taliercio, J. J. et al. Prognostic importance of serum alkaline phosphatase in CKD stages 3\u20134 in a clinical population. Am. J. Kidney Dis. 62, 703\u2013710 (2013).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201760_CR157","doi-asserted-by":"publisher","first-page":"e004275","DOI":"10.1136\/bmjopen-2013-004275","volume":"4","author":"J Beige","year":"2014","unstructured":"Beige, J. et al. Association of serum alkaline phosphatase with mortality in non-selected European patients with CKD5D: an observational, three-centre survival analysis. BMJ Open 4, e004275 (2014).","journal-title":"BMJ Open"},{"key":"BFnrneph201760_CR158","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1159\/000444890","volume":"43","author":"M Soohoo","year":"2016","unstructured":"Soohoo, M. et al. Changes in markers of mineral and bone disorders and mortality in incident hemodialysis patients. Am. J. Nephrol. 43, 85\u201396 (2016).","journal-title":"Am. J. Nephrol."},{"key":"BFnrneph201760_CR159","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.2215\/CJN.01910212","volume":"7","author":"MZ Molnar","year":"2012","unstructured":"Molnar, M. Z., Kovesdy, C. P., Mucsi, I., Salusky, I. B. & Kalantar-Zadeh, K. Association of pre-kidney transplant markers of mineral and bone disorder with post-transplant outcomes. Clin. J. Am. Soc. Nephrol. 7, 1859\u20131871 (2012).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201760_CR160","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1600-6143.2009.02876.x","volume":"10","author":"DM Zelle","year":"2010","unstructured":"Zelle, D. M. et al. Markers of the hepatic component of the metabolic syndrome as predictors of mortality in renal transplant recipients. Am. J. Transplant. 10, 106\u2013114 (2010).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph201760_CR161","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1159\/000169030","volume":"16","author":"RN Foley","year":"1996","unstructured":"Foley, R. N. et al. Hypocalcemia, morbidity, and mortality in end-stage renal disease. Am. J. Nephrol. 16, 386\u2013393 (1996).","journal-title":"Am. J. Nephrol."},{"key":"BFnrneph201760_CR162","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1097\/MD.0000000000000106","volume":"93","author":"JF Chang","year":"2014","unstructured":"Chang, J. F. et al. Combined alkaline phosphatase and phosphorus levels as a predictor of mortality in maintenance hemodialysis patients. Medicine (Baltimore) 93, e106 (2014).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrneph201760_CR163","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1159\/000357640","volume":"37","author":"HR Chua","year":"2014","unstructured":"Chua, H. R. et al. Predicting first-year mortality in incident dialysis patients with end-stage renal disease \u2014 the UREA5 study. Blood Purif. 37, 85\u201392 (2014).","journal-title":"Blood Purif."},{"key":"BFnrneph201760_CR164","doi-asserted-by":"publisher","first-page":"e0129737","DOI":"10.1371\/journal.pone.0129737","volume":"10","author":"YC Lin","year":"2015","unstructured":"Lin, Y. C. et al. Effect modifying role of serum calcium on mortality-predictability of PTH and alkaline phosphatase in hemodialysis patients: an investigation using data from the Taiwan Renal Registry Data System from 2005 to 2012. PLoS ONE 10, e0129737 (2015).","journal-title":"PLoS ONE"},{"key":"BFnrneph201760_CR165","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1159\/000443451","volume":"41","author":"JG Zhu","year":"2016","unstructured":"Zhu, J. G. et al. Serum alkaline phosphatase levels are not associated with increased death risk in prevalent hemodialysis patients: 5-year experience in a single hemodialysis center. Kidney Blood Press. Res. 41, 498\u2013506 (2016).","journal-title":"Kidney Blood Press. Res."},{"key":"BFnrneph201760_CR166","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000438999","volume":"42","author":"JJ Scialla","year":"2015","unstructured":"Scialla, J. J. et al. Race, mineral homeostasis and mortality in patients with end-stage renal disease on dialysis. Am. J. Nephrol. 42, 25\u201334 (2015).","journal-title":"Am. J. Nephrol."},{"key":"BFnrneph201760_CR167","doi-asserted-by":"publisher","unstructured":"Sumida, K. et al. Prognostic significance of pre-end-stage renal disease serum alkaline phosphatase for post-end-stage renal disease mortality in late-stage chronic kidney disease patients transitioning to dialysis. Nephrol. Dial. Transplant. http:\/\/dx.doi.org\/10.1093\/ndt\/gfw412 (2017).","DOI":"10.1093\/ndt\/gfw412"},{"key":"BFnrneph201760_CR168","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1093\/clinchem\/23.12.2263","volume":"23","author":"JP Bretaudiere","year":"1977","unstructured":"Bretaudiere, J. P. et al. Criteria for establishing a standardized method for determining alkaline phosphatase activity in human serum. Clin. Chem. 23, 2263\u20132274 (1977).","journal-title":"Clin. Chem."},{"key":"BFnrneph201760_CR169","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/clinchem\/30.5.704","volume":"30","author":"NW Tietz","year":"1984","unstructured":"Tietz, N. W. et al. Transferability studies for the AACC reference method and the IFCC method for measurement of alkaline phosphatase activity. Clin. Chem. 30, 704\u2013706 (1984).","journal-title":"Clin. Chem."},{"key":"BFnrneph201760_CR170","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD\u2013MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int. Suppl. 76, S1\u2013S130 (2009)."},{"key":"BFnrneph201760_CR171","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.lfs.2011.11.006","volume":"90","author":"I Kobayashi","year":"2012","unstructured":"Kobayashi, I. et al. Higher serum bone alkaline phosphatase as a predictor of mortality in male hemodialysis patients. Life Sci. 90, 212\u2013218 (2012).","journal-title":"Life Sci."},{"key":"BFnrneph201760_CR172","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/ki.2012.77","volume":"82","author":"S Sardiwal","year":"2012","unstructured":"Sardiwal, S. et al. Bone-specific alkaline phosphatase concentrations are less variable than those of parathyroid hormone in stable hemodialysis patients. Kidney Int. 82, 100\u2013105 (2012).","journal-title":"Kidney Int."},{"key":"BFnrneph201760_CR173","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.2215\/CJN.09471209","volume":"5","author":"C Gardham","year":"2010","unstructured":"Gardham, C. et al. Variability of parathyroid hormone and other markers of bone mineral metabolism in patients receiving hemodialysis. Clin. J. Am. Soc. Nephrol. 5, 1261\u20131267 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201760_CR174","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2215\/CJN.09580911","volume":"8","author":"G Garrett","year":"2013","unstructured":"Garrett, G., Sardiwal, S., Lamb, E. J. & Goldsmith, D. J. PTH \u2014 a particularly tricky hormone: why measure it at all in kidney patients? Clin. J. Am. Soc. Nephrol. 8, 299\u2013312 (2013).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201760_CR175","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3747\/pdi.2014.00246","volume":"34","author":"EJ Lamb","year":"2014","unstructured":"Lamb, E. J. & Delaney, M. P. Does PTH offer additive value to ALP measurement in assessing CKD-MBD? Perit. Dial. Int. 34, 687\u2013691 (2014).","journal-title":"Perit. Dial. Int."},{"key":"BFnrneph201760_CR176","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1359\/JBMR.040608","volume":"19","author":"A Kozlenkov","year":"2004","unstructured":"Kozlenkov, A. et al. Residues determining the binding specificity of uncompetitive inhibitors to tissue-nonspecific alkaline phosphatase. J. Bone Miner. Res. 19, 1862\u20131872 (2004).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrneph201760_CR177","doi-asserted-by":"publisher","first-page":"6919","DOI":"10.1021\/jm900383s","volume":"52","author":"R Dahl","year":"2009","unstructured":"Dahl, R. et al. Discovery and validation of a series of aryl sulfonamides as selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP). J. Med. Chem. 52, 6919\u20136925 (2009).","journal-title":"J. Med. Chem."},{"key":"BFnrneph201760_CR178","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1177\/1087057109338517","volume":"14","author":"E Sergienko","year":"2009","unstructured":"Sergienko, E. et al. Identification and characterization of novel tissue-nonspecific alkaline phosphatase inhibitors with diverse modes of action. J. Biomol. Screen. 14, 824\u2013837 (2009).","journal-title":"J. Biomol. Screen."},{"key":"BFnrneph201760_CR179","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.bmcl.2008.10.107","volume":"19","author":"S Sidique","year":"2009","unstructured":"Sidique, S. et al. Design and synthesis of pyrazole derivatives as potent and selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP). Bioorg. Med. Chem. Lett. 19, 222\u2013225 (2009).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"BFnrneph201760_CR180","doi-asserted-by":"publisher","first-page":"7981","DOI":"10.1016\/j.bmc.2013.09.053","volume":"21","author":"J Debray","year":"2013","unstructured":"Debray, J. et al. Inhibitors of tissue-nonspecific alkaline phosphatase: design, synthesis, kinetics, biomineralization and cellular tests. Bioorg. Med. Chem. 21, 7981\u20137987 (2013).","journal-title":"Bioorg. Med. Chem."},{"key":"BFnrneph201760_CR181","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.bmcl.2016.01.061","volume":"26","author":"S Marques","year":"2016","unstructured":"Marques, S., Buchet, R., Popowycz, F., Lemaire, M. & Mebarek, S. Synthesis of benzofuran derivatives as selective inhibitors of tissue-nonspecific alkaline phosphatase: effects on cell toxicity and osteoblast-induced mineralization. Bioorg. Med. Chem. Lett. 26, 1457\u20131459 (2016).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"BFnrneph201760_CR182","doi-asserted-by":"publisher","first-page":"19754","DOI":"10.1073\/pnas.1310658110","volume":"110","author":"S Picaud","year":"2013","unstructured":"Picaud, S. et al. RVX-208, an inhibitor of bet transcriptional regulators with selectivity for the second bromodomain. Proc. Natl Acad. Sci. USA 110, 19754\u201319759 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201760_CR183","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.atherosclerosis.2016.01.036","volume":"247","author":"D Gilham","year":"2016","unstructured":"Gilham, D. et al. RVX-208, a bet-inhibitor for treating atherosclerotic cardiovascular disease, raises Apoa-I\/HDL and represses pathways that contribute to cardiovascular disease. Atherosclerosis 247, 48\u201357 (2016).","journal-title":"Atherosclerosis"},{"key":"BFnrneph201760_CR184","first-page":"227A","volume":"26","author":"K Kalantar-Zadeh","year":"2015","unstructured":"Kalantar-Zadeh, K. et al. Alkaline phosphatase lowering by selective bet inhibition, a novel mechanism for mace reduction in high risk cvd, diabetes and CKD patients \u2014 a post-hoc analysis of phase 2b studies with RVX-208. J. Am. Soc. Nephrol. 26, 227A (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201760_CR185","doi-asserted-by":"publisher","first-page":"i109","DOI":"10.1093\/ndt\/gfw157.32","volume":"31","author":"NCW Wong","year":"2016","unstructured":"Wong, N. C. W. et al. Apabetalone (RVX-208), a selective bromodomain and extra-terminal (bet) protein inhibitor, decreases abundance and activity of complement proteins in vitro, in mice and in clinical studies. Nephrol. Dial. Transplant. 31, i109 (2016).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201760_CR186","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02586155 (2016)"},{"key":"BFnrneph201760_CR187","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1056\/NEJMoa1106173","volume":"366","author":"MP Whyte","year":"2012","unstructured":"Whyte, M. P. et al. Enzyme-replacement therapy in life-threatening hypophosphatasia. N. Engl. J. Med. 366, 904\u2013913 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201760_CR188","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1210\/jc.2015-3462","volume":"101","author":"MP Whyte","year":"2016","unstructured":"Whyte, M. P. et al. Asfotase alfa treatment improves survival for perinatal and infantile hypophosphatasia. J. Clin. Endocrinol. Metab. 101, 334\u2013342 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrneph201760_CR189","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/CCM.0b013e31819598af","volume":"37","author":"S Heemskerk","year":"2009","unstructured":"Heemskerk, S. et al. Alkaline phosphatase treatment improves renal function in severe sepsis or septic shock patients. Crit. Care Med. 37, 417\u2013423 (2009).","journal-title":"Crit. Care Med."},{"key":"BFnrneph201760_CR190","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2174\/187221309789257388","volume":"3","author":"S Kats","year":"2009","unstructured":"Kats, S. et al. Anti-inflammatory effects of alkaline phosphatase in coronary artery bypass surgery with cardiopulmonary bypass. Recent Pat. Inflamm. Allergy Drug Discov. 3, 214\u2013220 (2009).","journal-title":"Recent Pat. Inflamm. Allergy Drug Discov."},{"key":"BFnrneph201760_CR191","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s40262-016-0399-y","volume":"55","author":"E Peters","year":"2016","unstructured":"Peters, E. et al. Pharmacokinetic modeling and dose selection in a randomized, double-blind, placebo-controlled trial of a human recombinant alkaline phosphatase in healthy volunteers. Clin. Pharmacokinet. 55, 1227\u20131237 (2016).","journal-title":"Clin. Pharmacokinet."},{"key":"BFnrneph201760_CR192","doi-asserted-by":"publisher","first-page":"20139","DOI":"10.3390\/molecules191220139","volume":"19","author":"SS Ghosh","year":"2014","unstructured":"Ghosh, S. S., Gehr, T. W. & Ghosh, S. Curcumin and chronic kidney disease (CKD): major mode of action through stimulating endogenous intestinal alkaline phosphatase. Molecules 19, 20139\u201320156 (2014).","journal-title":"Molecules"},{"key":"BFnrneph201760_CR193","doi-asserted-by":"publisher","first-page":"e108577","DOI":"10.1371\/journal.pone.0108577","volume":"9","author":"SS Ghosh","year":"2014","unstructured":"Ghosh, S. S., Bie, J., Wang, J. & Ghosh, S. Oral supplementation with non-absorbable antibiotics or curcumin attenuates Western diet-induced atherosclerosis and glucose intolerance in LDLR\u2212\/\u2212 mice \u2014 role of intestinal permeability and macrophage activation. PLoS ONE 9, e108577 (2014).","journal-title":"PLoS ONE"}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2017.60.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2017.60","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nrneph.2017.60","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2017.60.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:51:30Z","timestamp":1684471890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2017.60"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,15]]},"references-count":193,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["BFnrneph201760"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2017.60","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,15]]},"assertion":[{"value":"15 May 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}